|
Volumn 35, Issue 1, 2002, Pages 12-18
|
Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: Results of a randomized, double-blind, parallel-group multicenter study
a a a a
a
NONE
(Germany)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
IDEBENONE;
PLACEBO;
TACRINE;
ADULT;
AGED;
ALZHEIMER DISEASE;
ARTICLE;
CLINICAL TRIAL;
COGNITION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DAILY LIFE ACTIVITY;
DEMENTIA;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FUNCTIONAL ASSESSMENT;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PARALLEL DESIGN;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
ANTIOXIDANTS;
BENZOQUINONES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NOOTROPIC AGENTS;
TACRINE;
TREATMENT OUTCOME;
|
EID: 0036172871
PISSN: 01763679
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2002-19833 Document Type: Article |
Times cited : (73)
|
References (28)
|